Profilo
Brent Meadows served as the Chief Business Officer at Medicenna Therapeutics Corp.
in 2023 and previously held the same position at OncoOne Research & Development GmbH.
He earned an MBA from Babson College and an undergraduate degree from the University of Richmond.
Precedenti posizioni note di Brent Meadows
Società | Posizione | Fine |
---|---|---|
MEDICENNA THERAPEUTICS CORP. | Corporate Officer/Principal | 26/10/2023 |
OncoOne Research & Development GmbH
OncoOne Research & Development GmbH BiotechnologyHealth Technology OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria. | Corporate Officer/Principal | - |
Formazione di Brent Meadows
Babson College | Masters Business Admin |
University of Richmond | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEDICENNA THERAPEUTICS CORP. | Health Technology |
Aziende private | 1 |
---|---|
OncoOne Research & Development GmbH
OncoOne Research & Development GmbH BiotechnologyHealth Technology OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria. | Health Technology |
- Borsa valori
- Insiders
- Brent Meadows